StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
AbCellera Biologics Inc.
NasdaqGS:ABCL
Sector
Location
Market Cap
USD 1.27 B
Share Price
USD 4.24
Avg Daily Volume
5,454,155
Change (1 day)
5.74%
Change (1 year)
35.90%
Change (YTD)
44.71%
AbCellera Biologics Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2025: USD -203.72 M
AbCellera Biologics Inc. EBITDA is USD -203.72 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 6.74% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
-
AbCellera Biologics Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -190.85 M, a 1,551.85% change year over year.
-
AbCellera Biologics Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -11.55 M, a -103.70% change year over year.
-
AbCellera Biologics Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 311.96 M, a -7.25% change year over year.
-
AbCellera Biologics Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 336.34 M.
Competitors
MERCK Kommanditgesellschaft auf Aktien
USD 128.13
MRK.DE
-3.71
-2.82%
Tempus AI, Inc.
USD 57.82
TEM
+0.94
1.65%
Twist Bioscience Corporation
USD 37.80
TWST
-0.23
-0.60%
Apogee Therapeutics, Inc.
USD 38.88
APGE
+0.74
1.94%
Schrödinger, Inc.
USD 21.14
SDGR
+0.13
0.62%
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Novo Nordisk A/S
USD 69.36
NOVO-B.CO
+0.76
1.10%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
Novartis AG
USD 120.84
NOVN.SW
+0.06
0.05%
Abbott Laboratories
USD 132.03
ABT
+0.01
0.01%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Thermo Fisher Scientific Inc.
USD 425.34
TMO
-9.52
-2.19%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Boston Scientific Corporation
USD 104.33
BSX
+1.13
1.09%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Vertex Pharmaceuticals Incorporated
USD 472.35
VRTX
+3.50
0.75%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Bristol-Myers Squibb Company
USD 47.34
BMY
+0.48
1.02%
Key Data
| Date | EBITDA | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) |
|---|
Competitors
MERCK Kommanditgesellschaft auf Aktien
USD 128.13
MRK.DE
-3.71
-2.82%
Tempus AI, Inc.
USD 57.82
TEM
+0.94
1.65%
Twist Bioscience Corporation
USD 37.80
TWST
-0.23
-0.60%
Apogee Therapeutics, Inc.
USD 38.88
APGE
+0.74
1.94%
Schrödinger, Inc.
USD 21.14
SDGR
+0.13
0.62%
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Novo Nordisk A/S
USD 69.36
NOVO-B.CO
+0.76
1.10%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
Novartis AG
USD 120.84
NOVN.SW
+0.06
0.05%
Abbott Laboratories
USD 132.03
ABT
+0.01
0.01%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Thermo Fisher Scientific Inc.
USD 425.34
TMO
-9.52
-2.19%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Boston Scientific Corporation
USD 104.33
BSX
+1.13
1.09%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Vertex Pharmaceuticals Incorporated
USD 472.35
VRTX
+3.50
0.75%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Bristol-Myers Squibb Company
USD 47.34
BMY
+0.48
1.02%